--- title: 大阪大学ベンチャーキャピタル｜社員紹介 image: https://www.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/ogp.png description: MEMBER一覧ページです。大阪大学ベンチャーキャピタルは、大阪大学を始めとする国立大学の世界屈指の研究成果の社会創出を目指し、投資を通じて大学発の新産業の事業化及び事業支援を行います。 --- [![](https://www.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/header_logo.svg)](https://www.ouvc.co.jp/en/?hsLang=en) - [ABOUT US](https://www.ouvc.co.jp/en/aboutus?hsLang=en) - [![](https://www.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/headerBtn_company.jpg) COMPANY](https://www.ouvc.co.jp/en/aboutus?hsLang=en) - [![](https://www.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/headerBtn_fund.jpg) FUND](https://www.ouvc.co.jp/en/fund?hsLang=en) - [NEWS](https://blog.ouvc.co.jp/en/?hsLang=en) - [PORTFOLIO](https://www.ouvc.co.jp/en/portfolio?hsLang=en) - [MEMBER](https://www.ouvc.co.jp/en/member) - [CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en) - [JP](https://www.ouvc.co.jp/member?hsLang=ja)/EN [JP](https://www.ouvc.co.jp/member?hsLang=ja)/EN [![](https://www.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/header_logo.svg)](https://www.ouvc.co.jp/en/?hsLang=en) - [ABOUT US](https://www.ouvc.co.jp/en/aboutus?hsLang=en) - [COMPANY](https://www.ouvc.co.jp/en/aboutus?hsLang=en) - [FUND](https://www.ouvc.co.jp/en/fund?hsLang=en) - [NEWS](https://blog.ouvc.co.jp/?hsLang=en) - [PORTFOLIO](https://www.ouvc.co.jp/en/portfolio?hsLang=en) - [MEMBER](https://www.ouvc.co.jp/en/member) - [CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en) ## MEMBER [HOME](https://www.ouvc.co.jp/?hsLang=en) MEMBER - ![img\_member\_05](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_05.jpg) Akira Uotani President ＆ CEO ![img\_member\_detail\_05](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_05.jpg) Akira Uotani 代表取締役社長 Akira Uotani joined Sumitomo Chemical Co., Ltd. in 2005, where he was engaged in research and development of high-performance materials, as well as planning new businesses. He subsequently supported venture creation activities at the National Institute of Advanced Industrial Science and Technology (AIST) before joining Osaka University Venture Capital in 2017. As a Capitalist, he primarily supports the creation of startups based on university research seeds (Company Creation), conducts investment activities, and provides management support to portfolio companies. He also oversees the overall management of OUVC. - ![img\_member\_14](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_14.jpg) Yuki Taga Director / Leader, Group 1, Investment Division ![img\_member\_detail\_14](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_14.jpg) Yuki Taga 投資部長第1グループリーダー Yuki Taga joined Sumitomo Electric Industries, Ltd. in 2012 after completing a master's degree in condensed matter physics. At Sumitomo Electric, he was engaged in the development of industrial equipment, plant start-up operations, and capital investment projects. After earning an MBA overseas, he joined Osaka University Venture Capital in 2022. As a venture capitalist, he supports the founding of university-based deep tech startups, makes early-stage investments, and provides management support to portfolio companies. - ![img\_member\_20\_1](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_20_1.jpg) Nozomu Mamiya Director, Corporate Planning & Administration Division ![img\_member\_detail\_20](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_20.jpg) Nozomu Mamiya 経営管理部長 Nozomu Mamiya joined Osaka University Venture Capital in 2022 after working at The Bank of Kyoto, Ltd. At Osaka University Venture Capital, he is responsible for startup investments, post-investment value enhancement and exit support, as well as corporate operations and fund administration. At The Bank of Kyoto, Ltd., he was engaged in corporate banking in the Kyoto and Osaka areas before joining the Head Office Sales Division, where he worked on startup support initiatives. He was involved in a wide range of startup support activities, including the establishment of and investment in various funds, business matching, and the planning and operation of seminars. - ![img\_member\_29](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_29.jpg) Shigehiro Asano Capitalist, Group 1, Investment Division ![img\_member\_detail\_29](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_29.jpg) Shigehiro Asano 投資部第1グループキャピタリスト Shigehiro Asano joined Osaka University Venture Capital in December 2024 after a career in drug discovery research at Sumitomo Pharma Co., Ltd. At Osaka University Venture Capital, he focuses primarily on venture investments and providing management support to portfolio companies.   In his previous role, he spent approximately 15 years as a medicinal chemist, conducting small molecule drug discovery research. He was also responsible for identifying and negotiating agreements for drug seeds and drug discovery-related technologies, as well as managing strategic alliances. - ![img\_member\_30](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_30.jpg) Hiroki Ikuta Capitalist, Group 1, Investment Division ![img\_member\_detail\_30](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_30.jpg) Hiroki Ikuta 投資部第1グループキャピタリスト Hiroki Ikuta joined Osaka University Venture Capital in January 2025, bringing experience from both local government and a consulting firm. At Osaka University Venture Capital, he focuses on venture investments and provides management support to portfolio companies. In his previous role at a consulting firm, Hiroki served as a project manager, driving digital transformation (DX), business development, and organizational reform initiatives. He guided clients across industries such as manufacturing, pharmaceuticals, healthcare, and energy, offering support from strategic planning through implementation. Hiroki also has hands-on experience in launching a medical AI startup, including developing its business plan. - ![img\_member\_31](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_31.jpg) Toshihiro Doi Capitalist, Group 1, Investment Division ![img\_member\_detail\_31](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_31.jpg) Toshihiro Doi 投資部第1グループキャピタリスト Toshihiro Doi was involved in the research, development, and business expansion of thin-film materials and portable genetic testing systems at Mitsubishi Materials Corporation. In the field of thin-film materials, he was responsible for the entire process, from researching and developing next-generation MEMS materials to bringing them to market and supporting customers in scaling up to mass production. In April 2025, he joined Osaka University Venture Capital, where he is primarily responsible for venture investments and providing management support to portfolio companies. - ![img\_member\_33](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_33.jpg) Akira Morimoto Recruiter, Group 1, Investment Division ![img\_member\_detail\_33](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_33.jpg) Akira Morimoto 投資部第1グループHR担当 Akira Morimoto began his career as a Medical Representative (MR) at a major pharmaceutical company. He later joined Recruit Co., Ltd., where he worked as a 360-degree recruiter and manager in the human resources placement division. He then served as a headhunter and Kansai area lead for the HR business at Sun\* Inc., a company specializing in new business development and digital transformation (DX). In June 2025, he joined Osaka University Venture Capital as the HR lead, supporting talent acquisition and organizational growth across its portfolio companies. - ![img\_member\_15](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_15.jpg) Aya Takahashi Group 1, Investment Division ![img\_member\_detail\_15](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_15.jpg) Aya Takahashi 投資部第1グループ Aya Takahashi joined Osaka University Venture Capital in 2019. She is responsible for supporting Investment Division operations and internal IT-related tasks. In her previous job, she worked in the fields of nuclear energy and embedded engineering. - ![img\_member\_12\_2](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_12_2.jpg) Yoshihiko Sakamoto Capitalist / Leader, Group 2, Investment Division ![img\_member\_detail\_12\_1](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_12_1.jpg) Yoshihiko Sakamoto 投資部キャピタリスト / 第2グループリーダー Yoshihiko Sakamoto joined Japan Asia Investment Co., Ltd. in 1991 and joined Osaka University Venture Capital in January 2015, where he became involved in its investment activities. He led investments in JTEC Corporation, Kringle Pharma, Inc., and Microwave Chemical Co., Ltd., which achieved IPOs as portfolio companies of OUVC 1st Investment Limited Partnership, as well as KOTAI Biotechnologies, Inc., which achieved an exit through M&A. As a lead VC, he also led the exits of Nanophoton Corporation and AI Samurai Inc. through M&A, as well as multiple exits through trade sales. At Japan Asia Investment Co., Ltd., he led exits through IPOs and M&As for more than a dozen companies in the investment division. He was appointed Executive Officer in 2008 and provided hands-on support to venture businesses according to their stage of growth, including securing management talent, strengthening sales organizations, arranging capital and business alliances, and establishing governance and IPO structures. He also conducted fundraising for multiple VC funds. - ![img\_member\_28\_4](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_28_4.jpg) Monta Sakaki Capitalist, Group 2, Investment Division ![img\_member\_detail\_28\_4](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_28_4.jpg) Monta Sakaki 投資部第2グループキャピタリスト Monta Sakaki was engaged in domestic investment operations in a wide range of fields at a securities-affiliated venture capital firm. He joined Osaka University Venture Capital in 2019 after working in university-industry collaboration and in planning and management at a robotics venture. He then served as the head of administration at a drug discovery startup of a portfolio company in 2023, and returned to Osaka University Venture Capital in August 2024. He is in charge of investing in university-originated ventures and management support. - ![img\_member\_34](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_34.jpg) Kosuke Ishii Associate, Group 2, Investment Division ![img\_member\_detail\_34](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_34.jpg) Kosuke Ishii 投資部第2グループアソシエイト After joining The Senshu Ikeda Bank, Kosuke Ishii began his career as a trainee in the Loan Department and then spent eight years in corporate sales, providing financing and business solution proposals to corporate clients. He subsequently worked for three years in the Regional Co-Creation and Innovation Department, where he was engaged in ICT consulting to help local companies improve operational efficiency and productivity. Since October 2025, he has been seconded to Osaka University Venture Capital. By leveraging the strengths of both university-based venture capital and regional financial institutions, he is committed to revitalizing the Kansai economy through investment in and management support for startups. - ![img\_member\_08](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_08.jpg) Masahiro Uehira Senior Venture Partner / Leader, Group 3, Investment Division ![img\_member\_detail\_08](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_08.jpg) Masahiro Uehira 投資部シニアベンチャーパートナー / 第3グループリーダー At Shionogi & Co., Ltd., Dr. Masahiro Uehira was engaged in drug discovery research, clinical development, and project management, leading the launch of multiple pharmaceutical products and global development projects with overseas companies. He also has extensive experience in regulatory affairs and business development. He joined Osaka University Venture Capital in 2018. In addition to technology evaluation and investment in the drug discovery and life sciences fields, he draws on his experience in research and development, clinical development, regulatory affairs, project management, and business development to provide hands-on support to portfolio companies and engage in venture creation. He works to translate the results of academic research into commercialization and implementation in society, and to contribute to the development of the life sciences venture ecosystem through collaboration with academia, industry, government, investors, and other stakeholders. - ![img\_member\_13](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_13.jpg) Hiroki Sato Senior Venture Partner, Group 3, Investment Division ![img\_member\_detail\_13](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_13.jpg) Hiroki Sato 投資部第3グループシニアベンチャーパートナー Hiroki Sato joined Osaka University Venture Capital in October 2022 after working at five pharmaceutical companies. He is currently responsible for the technical assessment of drug discovery and life science-related seed technologies. In his previous job, he worked at a pharmaceutical company for 25 years in drug discovery research (medicinal chemistry; metabolic diseases, respiratory diseases, etc.) and drug development research. After that, he gained experience in business development work such as alliance management and licensing out (cancer fields) mainly for European and American pharmaceutical companies, as well as management work in planning, drafting, and implementing epidemiological research, and managing presentations of clinical trial results at academic conferences and publication of papers (in the pain and cancer fields). - ![img\_member\_23\_1](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_23_1.jpg) Yoshiyuki Shimekake Venture Partner, Group 3, Investment Division ![img\_member\_detail\_23](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_23.jpg) Yoshiyuki Shimekake 投資部第3グループベンチャーパートナー Yoshiyuki Shimekake joined Osaka University Venture Capital in November 2023, where he is responsible for evaluating the technological potential and commercial viability of early-stage opportunities, as well as supporting venture creation. Prior to joining Osaka University Venture Capital, he conducted research on the physiological functions of peptides and nucleic acid therapeutics. He subsequently worked in the Business Development Department, where he was involved in the identification of drug discovery seeds and technologies, licensing negotiations, and alliance management. - ![img\_member\_10](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_10.jpg) Serina Oda Corporate Planning & Administration Division ![img\_member\_detail\_10](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_10.jpg) Serina Oda 経営管理部 Serina Oda joined Osaka University Venture Capital in 2017. In the Administration department, she is responsible for various back-office functions, including human resources, general affairs, and accounting. - ![img\_member\_32\_1](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_32_1.jpg) Noriyuki Minamitani Corporate Planning & Administration Division ![img\_member\_detail\_32](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_32.jpg) Noriyuki Minamitani 経営管理部 Noriyuki Minamitani joined The Kinki Osaka Bank, Ltd. (now Kansai Mirai Bank, Limited) in 2014. He has been seconded to Osaka University Venture Capital since April 2025. In the Corporate Planning & Administration Division, he is involved in supporting the exit strategies of portfolio companies, portfolio monitoring, and identifying additional investment opportunities. At Kansai Mirai Bank, Limited, he worked in corporate banking for small and medium-sized enterprises at a branch office. - ![img\_member\_36](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_36.jpg) Akiyo Ichikawa Corporate Planning & Administration Division ![img\_member\_detail\_36](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_36.jpg) Akiyo Ichikawa 経営管理部 Akiyo Ichikawa has experience in product planning for lighting equipment, back-office operations and IPO preparation at a hardware startup, as well as financial administration at a private university. She joined Osaka University Venture Capital in 2026. In the Corporate Planning & Administration Division, she is responsible for a wide range of back-office operations. - ![img\_member\_37](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_37.jpg) Naoki Matsushita Corporate Planning & Administration Division ![img\_member\_detail\_37](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_37.jpg) Naoki Matsushita 経営管理部 Naoki Matsushita joined Japan Finance Corporation in 2014. He has been seconded to Osaka University Venture Capital since August 2026. In the Corporate Planning & Administration Division, he is involved in supporting the exit strategies of portfolio companies, portfolio monitoring, and assessing follow-on investments. At Japan Finance Corporation, he worked at the Startup Support Plaza, where he provided financing consultations and conducted credit assessments for startups. He was also involved in planning and organizing seminars and startup-related events.       ― EIR ―     - ![img\_member\_35](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_35.jpg) Masato Ishiwata Entrepreneur In Residence ![img\_member\_detail\_35](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_35.jpg) Masato Ishiwata 客員起業家 Masato Ishiwata has more than 20 years of experience in business development, international sales, and marketing in the pharmaceutical and biotechnology industries, as well as four years of experience in regulatory affairs such as CTD preparation for biologics. As the head of Business Development, he has successfully led 2 biotech start-ups, Cellseed Inc. and Tsubota Lab Inc., to IPO. He joined Osaka University Venture Capital as an Entrepreneur in Residence (EIR) from November 2025. - ![img\_member\_38](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_38.jpg) Ayako Kawase Entrepreneur In Residence ![img\_member\_detail\_38](https://www.ouvc.co.jp/hubfs/00_DC_%E5%A4%A7%E9%98%AA%E5%A4%A7%E5%AD%A6%E3%83%99%E3%83%B3%E3%83%81%E3%83%A3%E3%83%BC%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB/%E7%A4%BE%E5%93%A1%E7%B4%B9%E4%BB%8B/img_member_detail_38.jpg) Ayako Kawase 客員起業家 Ayako Kawase has over 15 years of experience in next-generation battery development across Japan and the United States. She earned a Ph.D. focused on sulfur battery research and is currently pursuing an MBA. In the United States, she led next-generation battery development projects at Lawrence Berkeley National Laboratory and a startup company. In Japan, she served as Head of Next-Generation Battery Development at a battery manufacturer and worked as an engineer at a leading automotive manufacturer. Since August 2026, she has been involved in the battery business as an Entrepreneur in Residence (EIR) at Osaka University Venture Capital. [![](https://www.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/footer__logo.svg)](https://www.ouvc.co.jp/en/?hsLang=en) OSAKA University Venture Capital 3F, TechnoAlliance Complex, 2-8 Yamadaoka, Suita City Osaka 565-0871 ### CONTACT Please feel free to contact us for a consultation. [CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en) [ABOUT US](https://www.ouvc.co.jp/en/aboutus?hsLang=en) [COMPANY](https://www.ouvc.co.jp/en/aboutus?hsLang=en) [FUND](https://www.ouvc.co.jp/en/fund?hsLang=en) [PORTFOLIO](https://www.ouvc.co.jp/en/portfolio?hsLang=en) [MEMBER](https://www.ouvc.co.jp/en/member) [CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en) [THE UNIVERSITY OF OSAKA](https://www.osaka-u.ac.jp/ja) [Co-Creation Bureau, the University of Osaka](https://www.ccb.osaka-u.ac.jp) [FUND COORDINATION](https://www.ouvc.co.jp/en/link?hsLang=en) Copyright 2023 OSAKA University Venture Capital Co., Ltd. All Rights Reserved. [CORPORATE POLICIES](https://connect.ouvc.co.jp/en/corporate-policies?hsLang=en) ![](https://www.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/arrow_top.svg) ![閉じる](https://www.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/modal_close.svg) ### Career ### Work history ### Education background ### Experience